Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anniina J Valkama

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|April 30, 2020
Development of Large-Scale Downstream Processing for Lentiviral VectorsAnniina J Valkama, Igor Oruetxebarria, Eevi M Lipponen, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent CellsHanna M Leinonen, Eevi M Lipponen, Anniina J Valkama, et al.
Frontiers in Medicine|March 20, 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapyReetta A E Eriksson, Tiina Nieminen, Lionel Galibert, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|April 30, 2020
Development of Large-Scale Downstream Processing for Lentiviral VectorsAnniina J Valkama, Igor Oruetxebarria, Eevi M Lipponen, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent CellsHanna M Leinonen, Eevi M Lipponen, Anniina J Valkama, et al.
Frontiers in Medicine|March 20, 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapyReetta A E Eriksson, Tiina Nieminen, Lionel Galibert, et al.
Pageof 1